Coronavirus
FDA authorizes first over-the-counter COVID-19 test
The FDA has authorized the first over-the-counter COVID-19 test for home use, but buyers still have to send their samples to a lab for processing.
The quest for a “warm” COVID-19 vaccine
Developers are on the hunt for a warm COVID-19 vaccine, one that could be distributed in places where a reliable cold chain isn’t available.
Congo just used vaccines to beat Ebola. What they learned could stop COVID, too.
Congo’s recent success delivering frigid Ebola vaccines to remote areas may provide invaluable experience for a COVID-19 vaccine cold chain.
The hep C cure may also fight COVID-19
SARS-CoV-2 uses a number of key proteins to infect us, including its main protease. New research has found hepatitis C drugs can bind this protein.
When will we have a COVID-19 vaccine?
Several developers have reported incredible coronavirus vaccine progress, so when will we have a COVID-19 vaccine ready for distribution?
Oxford says its COVID-19 vaccine is up to 90% effective
The University of Oxford's COVID-19 vaccine was up to 90% effective in a phase 3 trial and could be easier to distribute than other coronavirus vaccines.
How long will coronavirus immunity last?
Coronavirus immunity might last for years, according to a new study that measured the levels of virus-fighting immune cells in COVID-19 survivors.
New skin cancer vaccine is twice as powerful
By adding two “boosters” to an in-development skin cancer vaccine, scientists may have improved its ability to prevent melanoma recurrence.
FDA authorizes first at-home COVID-19 test
The FDA has authorized an at-home COVID-19 test that delivers results in 30 minutes, but you can’t get it without a prescription.
Trial suggests Moderna’s coronavirus vaccine is 95% effective
Another win for mRNA vaccines: Moderna’s coronavirus vaccine appears to be 94.5% effective at preventing COVID-19, according to initial trial data.